ArticleDrugs in R&D2023

A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetics of Napabucasin Combined with Sorafenib in Japanese Patients with Unresectable Hepatocellular Carcinoma.

Takuji Okusaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.